We are live on
!
Find out more
DRD
Dennis R. Delaney Portfolio holdings
AUM
$282M
1-Year Est. Return
16.32%
This Fund
S&P 500
This Quarter
Est. Return
+10.64%
1 Year Est. Return
+16.32%
3 Year Est. Return
+57.02%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$14.7M
(+8.7%)
Cap. Flow
+$382K
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
42.39%
Holding
46
New
4
Increased
19
Reduced
18
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ball Corp
BALL
|
+$563K |
| 2 |
Carrier Global
CARR
|
+$561K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$523K |
| 4 |
UnitedHealth
UNH
|
+$170K |
| 5 |
Danaher
DHR
|
+$160K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$726K |
| 2 |
CVS Health
CVS
|
+$363K |
| 3 |
Intel
INTC
|
+$201K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$197K |
| 5 |
Mastercard
MA
|
+$195K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.86% |
| 2 | Healthcare | 23.5% |
| 3 | Industrials | 13.33% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Consumer Staples | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$465B
| $2.81M | 1.53% |
15,412
| – | – |
|
|
NVO
27
Novo Nordisk
NVO
$225B
| $2.33M | 1.27% |
18,140
-20
| -0.1% | -$2.38K |
|
28
Becton Dickinson
BDX
$45.8B
| $2.33M | 1.27% |
9,404
+55
| +0.6% | +$13.2K |
|
|
29
Novartis
NVS
$304B
| $2.3M | 1.25% |
23,775
-7,080
| -23% | -$726K |
|
30
Nike
NKE
$63.9B
| $2.09M | 1.14% |
22,256
+10
| +0% | +$1.02K |
|
31
Medtronic
MDT
$111B
| $1.76M | 0.96% |
20,220
+180
| +0.9% | +$15.4K |
|
32
Norfolk Southern
NSC
$76.1B
| $1.63M | 0.89% |
6,400
| – | – |
|
|
33
CVS Health
CVS
$140B
| $1.53M | 0.83% |
19,141
-4,747
| -20% | -$363K |
|
34
General Mills
GIS
$20.1B
| $892K | 0.49% |
12,750
-2,000
| -14% | -$130K |
|
35
ConocoPhillips
COP
$139B
| $822K | 0.45% |
6,460
| – | – |
|
36
Union Pacific
UNP
$175B
| $765K | 0.42% |
3,112
| – | – |
|
37
Honeywell
HON
$78.3B
| $625K | 0.34% |
3,229
-164
| -5% | -$30.9K |
|
|
38
Ball Corp
BALL
$17.8B
| $624K | 0.34% |
+9,260
| New | +$563K |
|
|
39
Berkshire Hathaway Class B
BRK.B
$1.11T
| $591K | 0.32% |
1,405
-500
| -26% | -$197K |
|
|
40
Carrier Global
CARR
$52.5B
| $580K | 0.32% |
+9,980
| New | +$561K |
|
|
41
Vertex Pharmaceuticals
VRTX
$124B
| $517K | 0.28% |
+1,238
| New | +$523K |
|
|
42
Intel
INTC
$435B
| $260K | 0.14% |
5,890
-4,500
| -43% | -$201K |
|
43
Church & Dwight Co
CHD
$23.7B
| $203K | 0.11% |
1,950
-300
| -13% | -$30K |
|
44
BigBear.ai
BBAI
$1.32B
| $49.2K | 0.03% |
+24,000
| New | +$53.1K |
|
Similar funds
WE
TC
UFAC
DIP
3CP
MFG
BO
BA
Dennis R. Delaney's Q1 2024 Portfolio in Review
As of Q1 2024, Dennis R. Delaney held 46 positions worth $183M, up 8.7% from $169M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Dennis R. Delaney's Q1 2024 filing shows 4 new, 19 increased and 18 reduced positions. Its largest new stake was Ball Corp: 9,260 shares worth $624K. The largest sale was Novartis, an estimated $726K.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Dennis R. Delaney's largest Q1 2024 buy was Ball Corp: 9,260 shares worth $624K.
- Dennis R. Delaney added most to UnitedHealth in Q1 2024, an estimated $170K increase.
- Dennis R. Delaney's biggest Q1 2024 reduction was Novartis, cutting an estimated $726K.
- Dennis R. Delaney's ten largest holdings make up 42% of its $183M portfolio in Q1 2024.
- Dennis R. Delaney opened 4 new positions and closed 0 in Q1 2024.
- Dennis R. Delaney's portfolio value rose 8.7% quarter-over-quarter to $183M.
Based on Dennis R. Delaney's 13F filing for Q1 2024, filed 6 May 2024.